We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Abionic

Abionic SA is a medtech company commercializing a revolutionary nanofluidic technology, providing healthcare professi... read more Featured Products: More products

Download Mobile App




POC Sepsis Test Delivers Fast, Accurate and User-Friendly Results in Critical Care Settings

By LabMedica International staff writers
Posted on 07 Oct 2024
Print article
Image: The IVD CAPSULE PSP test PSP runs on the abioSCOPE near-patient rapid diagnostic platform (Photo courtesy of Abionic)
Image: The IVD CAPSULE PSP test PSP runs on the abioSCOPE near-patient rapid diagnostic platform (Photo courtesy of Abionic)

Sepsis is a critical global health issue, impacting 50 million people annually and causing 11 million deaths, which accounts for 20% of all global fatalities. Sepsis is an emergency where time is of the essence, and up to 80% of sepsis-related deaths are preventable. However, it remains notoriously difficult to diagnose due to its non-specific symptoms, which often mimic other common conditions. Early detection is essential for initiating the appropriate treatment protocols and improving patient survival rates. Pancreatic Stone Protein (PSP) has emerged as a promising biomarker for the early detection of sepsis, identifying the condition 24-48 hours earlier than current methods. PSP, produced by the pancreas and immune cells, rises in response to infection and inflammation and has shown significant sensitivity and specificity in detecting sepsis, particularly in critically ill patients. Clinical studies have found that elevated PSP levels are closely linked to the progression of sepsis, enabling healthcare providers to initiate life-saving treatments sooner and improve patient outcomes.

Abionic (Epalinges, Switzerland) has developed the IVD CAPSULE PSP test, which offers rapid, accurate, and easy-to-use results in critical care settings by measuring PSP levels. These measurements are directly tied to a patient's sepsis risk, empowering clinicians to make well-informed decisions and initiate timely treatments. The IVD CAPSULE PSP operates exclusively on Abionic’s abioSCOPE platform, a near-patient rapid diagnostic system that integrates smoothly into clinical workflows. It provides lab-quality results from a drop of blood within minutes, delivering valuable insights and actionable information directly at the point of care.

To perform the test, a trained healthcare provider can obtain 50 μL of capillary blood via a simple finger prick without the need for a phlebotomist to collect venous blood. The sample is placed into an abioMIX tube, shaken 10 times for even mixing, and then applied to the capsule. The biomarker levels are quickly measured with high precision and accuracy, delivering lab-quality results within minutes at the point of care. The IVD CAPSULE PSP test has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA), expediting the detection of sepsis. Already certified under the EU IVDR as of July 2022, this FDA approval allows Abionic to expand into the U.S. market.

“Achieving FDA 510(k) clearance for IVD CAPSULE PSP marks a significant milestone for Abionic and confirms our ability to meet the need for quick & reliable sepsis testing,” said Patrick Pestalozzi, CEO at Abionic. “This clearance will allow us to deploy our solutions across the United States and provide clinicians in acute care settings with a proven solution to accelerate the Time-To-Detection of sepsis.”

Related Links:
Abionic

New
Gold Member
ANA & ENA Screening Assays
ANA and ENA Assays
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Urine Drug Test
Instant-view Methadone Urine Drug Test
New
Laboratory Electric Thermostat
DNP-9025A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Immunology

view channel
Image: An immune response is initiated when an antigen-presenting cell (pink) presents foreign material to a T-cell (blue) (Photo courtesy of JAX)

Advanced Imaging Method Maps Immune Cell Connections to Predict Cancer Patients Survival

A growing tumor is influenced not only by the tumor cells themselves but also by the surrounding tissue, which alters its biology. Immune cells communicate by transferring vital signaling proteins to their... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: LMU’s Professor Frederick Klauschen developed the novel approach that can improve diagnostic accuracy (Photo courtesy of LMU Munich)

AI Tool Uses Imaging Data to Detect Less Frequent GI Diseases

Artificial intelligence (AI) is already being utilized in various medical fields, demonstrating significant potential in aiding doctors in diagnosing diseases through imaging data. However, training AI... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.